Join now

Profit or life? - The power of the pharmaceutical companies

Hosted by the Consul of the Munich New Horizons Group
Event Cover Photo
Took place 1 month ago
Mon 07 Dec 19:00 - 20:00

Ready to Join?

Watch this very interesting DW documentary about the power of the pharmaceutical companies any time you like. Please feel free to post your comments on the wall of this activity.
Protected content
Quote:
„How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?
In Protected content , the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency.
A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.“ End of Quote
Best regards
Peter